Zhu X - Search Results

1

Decoy receptor 3 (DcR3) overexpression predicts the prognosis and pN2 in pancreatic head carcinoma.

Zhou J, Song S, Li D, He S, Zhang B, Wang Z, Zhu X. Zhou J, et al. Among authors: zhu x. World J Surg Oncol. 2014 Mar 5;12:52. doi: 10.1186/1477-7819-12-52. World J Surg Oncol. 2014. PMID: 24597666 Free PMC article.

2

B7-H3 overexpression in pancreatic cancer promotes tumor progression.

Zhao X, Li DC, Zhu XG, Gan WJ, Li Z, Xiong F, Zhang ZX, Zhang GB, Zhang XG, Zhao H. Zhao X, et al. Among authors: zhu xg. Int J Mol Med. 2013 Feb;31(2):283-91. doi: 10.3892/ijmm.2012.1212. Epub 2012 Dec 13. Int J Mol Med. 2013. PMID: 23242015 Free PMC article.

3

Silencing of pancreatic adenocarcinoma upregulated factor by RNA interference inhibits the malignant phenotypes of human colorectal cancer cells.

Liu PF, Wu YY, Hu Y, Wang L, He SB, Zhu YB, Zhu XG. Liu PF, et al. Oncol Rep. 2013 Jul;30(1):213-20. doi: 10.3892/or.2013.2478. Epub 2013 May 15. Oncol Rep. 2013. PMID: 23677445

4

MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway.

Zhou J, Song S, He S, Zhu X, Zhang Y, Yi B, Zhang B, Qin G, Li D. Zhou J, et al. Among authors: zhu x. Int J Mol Med. 2014 Apr;33(4):950-6. doi: 10.3892/ijmm.2014.1638. Epub 2014 Jan 28. Int J Mol Med. 2014. PMID: 24481267

5

Effect of CLN3 silencing by RNA interference on the proliferation and apoptosis of human colorectal cancer cells.

Zhu X, Huang Z, Chen Y, Zhou J, Hu S, Zhi Q, Song S, Wang Y, Wan D, Gu W, Zhou H, Zhang B, Cao W, He S. Zhu X, et al. Biomed Pharmacother. 2014 Apr;68(3):253-8. doi: 10.1016/j.biopha.2013.12.010. Epub 2014 Jan 15. Biomed Pharmacother. 2014. PMID: 24556023

6

Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance.

He S, Zhou H, Zhu X, Hu S, Fei M, Wan D, Gu W, Yang X, Shi D, Zhou J, Zhou J, Zhu Z, Wang L, Li D, Zhang Y. He S, et al. Among authors: zhu x, zhu z. Biomed Pharmacother. 2014 Jun;68(5):507-13. doi: 10.1016/j.biopha.2014.03.016. Epub 2014 Mar 31. Biomed Pharmacother. 2014. PMID: 24751002

7

Depletion of RhoGDI2 expression inhibits the ability of invasion and migration in pancreatic carcinoma.

Yi B, Hu Y, Qin G, Gu W, Zhu X, He S, Zhou J, Li D. Yi B, et al. Among authors: zhu x. Int J Mol Med. 2014 Jul;34(1):205-12. doi: 10.3892/ijmm.2014.1765. Epub 2014 Apr 30. Int J Mol Med. 2014. PMID: 24788627

8

Inhibition of EZH2 expression is associated with the proliferation, apoptosis, and migration of SW620 colorectal cancer cells in vitro.

He SB, Zhou H, Zhou J, Zhou GQ, Han T, Wan DW, Gu W, Gao L, Zhang Y, Xue XF, Zhang LF, Fei M, Hu SQ, Yang XD, Zhu XG, Wang L, Li DC. He SB, et al. Exp Biol Med (Maywood). 2015 Apr;240(4):458-66. doi: 10.1177/1535370214542215. Epub 2014 Jul 8. Exp Biol Med (Maywood). 2015. PMID: 25005166 Free PMC article.

9

Interleukin‑21 promotes the development of ulcerative colitis and regulates the proliferation and secretion of follicular T helper cells in the colitides microenvironment.

Yu J, He S, Liu P, Hu Y, Wang L, Wang X, Han Y, Zhu X. Yu J, et al. Among authors: zhu x. Mol Med Rep. 2015 Feb;11(2):1049-56. doi: 10.3892/mmr.2014.2824. Epub 2014 Oct 30. Mol Med Rep. 2015. PMID: 25371082

10

Clinical Significance of miR-1826 as a Novel Prognostic Biomarker in Colorectal Cancer.

Hu Y, Yi B, He S, Gao L, Liu P, Wang L, Yu J, Wan D, Zhou J, Zhu X, Zhi Q. Hu Y, et al. Among authors: zhu x. Anticancer Agents Med Chem. 2016;16(9):1109-16. doi: 10.2174/1871520615666150507122434. Anticancer Agents Med Chem. 2016. PMID: 25968874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,541 results

Search Page

Filters